Technical Analysis for CPRX - Catalyst Pharmaceutical Partners, Inc.

Grade Last Price % Change Price Change
grade B 2.62 0.38% 0.01
CPRX closed up 0.38 percent on Friday, January 18, 2019, on 34 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
8 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical CPRX trend table...

Date Alert Name Type % Chg
Jan 18 Outside Day Range Expansion 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 17 Narrow Range Bar Range Contraction 0.38%
Jan 17 NR7 Range Contraction 0.38%
Jan 17 NR7-2 Range Contraction 0.38%
Jan 17 Inside Day Range Contraction 0.38%
Jan 17 Wide Bands Range Expansion 0.38%
Jan 17 Overbought Stochastic Strength 0.38%

Older signals for CPRX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. The company's principal product includes Firdapse that is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. It also develops CPP-115, a GABA aminotransferase inhibitor for the treatment of epilepsy and other selected central nervous disease indications; and CPP-109 for the treatment of Tourette Syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
Is CPRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 4 Catalyst Pharma up 7% on Firdapse data in myasthenia gravis
Jan 4 Catalyst Pharmaceuticals Announces Publication of Clinical Data from the Investigator-Sponsored Phase IIb Study Evaluating Firdapse® for the Treatment of MuSK Antibody Positive Myasthenia Gravis
Dec 21 The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Dec 19 Should You Buy Catalyst Pharmaceuticals, Inc. (CPRX)?
Dec 18 Catalyst Pharma up 5% on Endo deal for generic Sabril
Dec 18 Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets
Dec 18 Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved
Dec 14 Catalyst Pharma +3.4% as director buys 20,000 shares
Dec 14 Does Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Have A Volatile Share Price?
Dec 11 Report: Exploring Fundamental Drivers Behind Sabre, Catalyst Pharmaceuticals, Renewable Energy Group, Luminex, Parker Drilling, and Apollo Endosurgery — New Horizons, Emerging Trends, and Upcoming Developments
See more CPRX news...
Indicators
Indicator Value
52 Week High 4.05
52 Week Low 1.85
Average Volume 2,344,831
200-Day Moving Average 2.9834
50-Day Moving Average 2.5382
20-Day Moving Average 2.3005
10-Day Moving Average 2.547
Average True Range 0.1588
ADX 21.08
+DI 24.8021
-DI 15.476
Chandelier Exit (Long, 3 ATRs ) 2.2236
Chandelier Exit (Short, 3 ATRs ) 2.3264
Upper Bollinger Band 2.8282
Lower Bollinger Band 1.7728
Percent B (%b) 0.8
BandWidth 45.876983
MACD Line 0.0465
MACD Signal Line -0.0149
MACD Histogram 0.0614
Fundamentals Value
Market Cap 221.53 Million
Num Shares 84.6 Million
EPS -0.20
Price-to-Earnings (P/E) Ratio -13.10
Price-to-Sales 0.00
Price-to-Book 6.97
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.74
Resistance 3 (R3) 2.73 2.69 2.72
Resistance 2 (R2) 2.69 2.66 2.69 2.71
Resistance 1 (R1) 2.65 2.64 2.67 2.66 2.71
Pivot Point 2.61 2.61 2.62 2.61 2.61
Support 1 (S1) 2.57 2.58 2.59 2.58 2.53
Support 2 (S2) 2.53 2.56 2.53 2.53
Support 3 (S3) 2.49 2.53 2.52
Support 4 (S4) 2.50